QXO Borrow Market Tightens as Short Sellers Keep Piling In
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Three lending-market signals converged on QXO this week. Short interest, cost to borrow, and availability all moved in the same direction simultaneously — a rare alignment that warrants attention.
Short Interest Hits 20.6% of Float
QXO's short interest climbed 12% in a single week to 20.6% of free float. Over the past month, it has risen 25%. FINRA's fortnightly settlement data put confirmed short shares at 132.8 million as of June 15 — days-to-cover stands at 7.71, meaning shorts would need more than a week of average volume to unwind.
The ORTEX short score sits at 79.8, placing QXO in the 1st percentile for short score rank across the market. That is an extreme reading.
The Borrow Pool Is Drying Up
Availability has collapsed. As recently as late May, availability was effectively zero — the lending pool was fully exhausted across multiple consecutive sessions from May 19 through May 28. It briefly reopened in early June, then tightened again. On June 24, availability dropped back to just 0.1% — one share available per thousand borrowed. As of the latest data, availability sits at roughly 13% — still deeply in "very tight" territory.
Cost to borrow reflects the squeeze. CTB surged 124% in one week to 4.12%. A month ago it was 3.19%. The direction is clear: lenders are charging more as supply thins out.
Options Traders Lean the Other Way
Here the picture gets more complex. The put/call ratio stands at 0.40 — near the 52-week low of 0.34 and well below the 20-day mean of 0.53. The PCR z-score is -1.78. Options positioning is distinctly call-heavy. That creates an unusual tension: short sellers are pressing hard through the stock loan market, while options traders are positioned for upside.
Analysts Still Bullish, But Trimming Targets
The analyst consensus remains constructive — price targets cluster around $31.50 against a current price of $17.78, implying material upside on consensus. But every recent analyst action since mid-May has been a target cut. Citigroup, Stephens, and Baird all trimmed in May. The bull case centres on QXO's acquisition-driven $50 billion revenue ambition. The bear case points to a projected ~19% EBITDA decline for FY26 and elevated SG&A spend.
- SI % of Free Float: 20.6% (up 12% week-on-week, up 25% month-on-month)
- Confirmed short shares (FINRA, June 15): 132.8M | Days-to-cover: 7.71
- Cost to borrow: 4.12% (+124% week-on-week)
- Availability: ~13% of estimated short interest — very tight
- 52-week availability low: 0.1% (hit June 24)
- ORTEX short score: 79.8 | Short score rank: 1st percentile
- Put/call ratio: 0.40 (z-score: -1.78; near 52-week low)
- Analyst consensus price target: $31.50 vs. current $17.78
- Next earnings: August 12, 2026
Stocks in this article
See the live data behind this article on ORTEX.
Open QXO on ORTEX →How this article was generated
- Generated
- 30 Jun 2026, 10:54
- Data as of
- 30 Jun 2026, 10:51
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.